https://european-biotechnology.net/wp-content/uploads/2024/12/Dewpoint-e1733404904642-1030x579-1.png5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-06 08:02:582024-12-12 10:02:07Dewpoint Therapeutics and Mitsubishi Tanabe partner on ALS therapy
https://european-biotechnology.net/wp-content/uploads/2024/12/Eli_Lilly_vials-e1733390268973.jpg225400Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-05 09:18:342024-12-12 10:02:07UK first country in Europe to reimburse tirzepatide
https://european-biotechnology.net/wp-content/uploads/2024/12/SLAS-International-e1733136334471.jpg451800Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-12-02 10:45:512024-12-12 10:02:07European Biotechnology and SLAS seal partnership
https://european-biotechnology.net/wp-content/uploads/2024/11/TeamCradle.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-27 08:34:592024-12-11 10:32:03Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering
https://european-biotechnology.net/wp-content/uploads/2024/11/Pharmamar-1030x669-1.png6691030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-25 14:58:092024-12-10 15:32:03EC ordered to pay cost of PharmaMar vs EMA case
https://european-biotechnology.net/wp-content/uploads/2024/11/NOD-Proteindesign.Andreas-HeddergottTUM-1030x579-1.png5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-22 07:18:252024-12-05 15:02:03New method set to speed up protein design
